Rubicon Organics Inc. (ROMJ.V)
CAD 0.49
(4.26%)
CAD 0.49
(4.26%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.94 Million CAD | 322.19% |
| 2022 | 217 Thousand CAD | 104.25% |
| 2021 | -10.86 Million CAD | -5.73% |
| 2020 | -10.37 Million CAD | -28.31% |
| 2019 | -8.04 Million CAD | 35.32% |
| 2018 | -9.01 Million CAD | -127.88% |
| 2017 | -5.53 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.83 Million CAD | 179.68% |
| 2024 Q1 | -3.55 Million CAD | -152.7% |
| 2023 Q4 | -1.77 Million CAD | -154.48% |
| 2023 Q2 | 614.83 Thousand CAD | 39.64% |
| 2023 FY | - CAD | -2105.95% |
| 2023 Q1 | 440.28 Thousand CAD | 122.84% |
| 2023 Q3 | -697.08 Thousand CAD | -213.38% |
| 2022 Q2 | -186.49 Thousand CAD | 57.3% |
| 2022 Q3 | 3.01 Million CAD | 1715.11% |
| 2022 FY | - CAD | 104.25% |
| 2022 Q1 | -436.78 Thousand CAD | 33.32% |
| 2022 Q4 | -1.92 Million CAD | -163.99% |
| 2021 FY | - CAD | -5.73% |
| 2021 Q4 | -655.04 Thousand CAD | 77.89% |
| 2021 Q3 | -2.96 Million CAD | 32.09% |
| 2021 Q2 | -4.36 Million CAD | -51.33% |
| 2021 Q1 | -2.88 Million CAD | 27.04% |
| 2020 Q3 | -3.11 Million CAD | -698.69% |
| 2020 Q2 | -390.01 Thousand CAD | 86.15% |
| 2020 FY | - CAD | -28.31% |
| 2020 Q1 | -2.81 Million CAD | -4914.11% |
| 2020 Q4 | -3.95 Million CAD | -26.82% |
| 2019 FY | - CAD | 35.32% |
| 2019 Q4 | 58.5 Thousand CAD | 101.75% |
| 2019 Q3 | -3.34 Million CAD | -17.08% |
| 2019 Q2 | -2.85 Million CAD | -52.72% |
| 2019 Q1 | -1.86 Million CAD | 54.16% |
| 2018 Q4 | -4.07 Million CAD | -16.05% |
| 2018 FY | - CAD | -127.88% |
| 2018 Q1 | -2.03 Million CAD | -37.57% |
| 2018 Q2 | -1.62 Million CAD | 20.3% |
| 2018 Q3 | -3.51 Million CAD | -116.29% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | -1.48 Million CAD | -27.15% |
| 2017 Q3 | -1.16 Million CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.68 Million CAD | 172.649% |
| CanadaBis Capital Inc. | 5.67 Million CAD | 65.692% |
| Decibel Cannabis Company Inc. | 5.67 Million CAD | 65.698% |
| Delivra Health Brands Inc. | 2.35 Million CAD | 17.247% |
| Entourage Health Corp. | -21.39 Million CAD | 109.104% |
| Lifeist Wellness Inc. | -12.76 Million CAD | 115.255% |
| Cannara Biotech Inc. | 17.18 Million CAD | 88.666% |
| Medicure Inc. | 1.27 Million CAD | -53.024% |
| PharmaCielo Ltd. | -12.01 Million CAD | 116.208% |
| BioSyent Inc. | 9.05 Million CAD | 78.493% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 259.548% |